CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 83 filers reported holding CYTOSORBENTS CORP in Q1 2020. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $174,000 | -23.7% | 54,600 | +0.2% | 0.00% | – |
| Q4 2021 | $228,000 | -48.5% | 54,500 | 0.0% | 0.00% | – |
| Q3 2021 | $443,000 | +7.8% | 54,500 | 0.0% | 0.00% | – |
| Q2 2021 | $411,000 | -9.5% | 54,500 | +4.2% | 0.00% | – |
| Q1 2021 | $454,000 | +8.9% | 52,300 | 0.0% | 0.00% | – |
| Q4 2020 | $417,000 | 0.0% | 52,300 | 0.0% | 0.00% | – |
| Q3 2020 | $417,000 | -19.5% | 52,300 | 0.0% | 0.00% | – |
| Q2 2020 | $518,000 | +51.5% | 52,300 | +18.3% | 0.00% | – |
| Q1 2020 | $342,000 | +302.4% | 44,200 | +100.9% | 0.00% | – |
| Q4 2019 | $85,000 | -23.4% | 22,000 | 0.0% | 0.00% | – |
| Q3 2019 | $111,000 | -23.4% | 22,000 | 0.0% | 0.00% | – |
| Q2 2019 | $145,000 | -3.3% | 22,000 | +11.1% | 0.00% | – |
| Q1 2019 | $150,000 | +66.7% | 19,800 | +78.4% | 0.00% | – |
| Q4 2018 | $90,000 | – | 11,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 249,430 | $2,015,000 | 1.24% |
| Manatuck Hill Partners, LLC | 194,100 | $1,568,000 | 0.81% |
| Skylands Capital, LLC | 495,850 | $4,006,000 | 0.66% |
| EAM Global Investors LLC | 78,027 | $630,000 | 0.34% |
| EAM Investors, LLC | 107,531 | $869,000 | 0.24% |
| Granahan Investment Management | 278,170 | $2,248,000 | 0.16% |
| Wealthcare Advisory Partners LLC | 62,079 | $502,000 | 0.10% |
| Avenir Corp | 76,390 | $617,000 | 0.08% |
| Crow Point Partners, LLC | 48,576 | $380,000 | 0.07% |
| Kalos Management, Inc. | 14,700 | $120,000 | 0.06% |